What is the appropriate starting dose of levothyroxine for a 27‑week pregnant woman with overt hypothyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Levothyroxine in Overt Hypothyroidism at 27 Weeks Pregnancy

For a 27-week pregnant woman with newly diagnosed overt hypothyroidism, start levothyroxine at 1.6 mcg/kg/day based on pre-pregnancy or current body weight immediately, and recheck TSH and free T4 in 4 weeks. 1

Critical Pre-Treatment Safety Assessment

Before initiating levothyroxine, you must rule out concurrent adrenal insufficiency by measuring morning cortisol and ACTH, as starting thyroid hormone before adequate corticosteroid coverage can precipitate life-threatening adrenal crisis 2. If adrenal insufficiency is present or suspected, initiate hydrocortisone for at least one week before starting levothyroxine 2.

Initial Dosing Strategy

The FDA-approved starting dose for new-onset hypothyroidism in pregnancy is 1.6 mcg/kg/day 1. This full replacement dose is appropriate because:

  • Untreated maternal hypothyroidism at 27 weeks carries unacceptable risks of preeclampsia, low birth weight, and permanent neurodevelopmental deficits in the child 2
  • Fetal brain development depends critically on maternal thyroid hormone, particularly in the second and third trimesters 2
  • Delayed treatment or underdosing increases risk of adverse pregnancy outcomes including gestational hypertension, stillbirth, and premature delivery 2

For a typical pregnant woman weighing 70 kg, this translates to approximately 112 mcg daily (round to 100-125 mcg) 1, 3. Use actual body weight for dose calculation, not ideal body weight 3, 4.

Monitoring Protocol During Pregnancy

Recheck TSH and free T4 every 4 weeks until stable, then at minimum once per trimester 1. The target is:

  • TSH within trimester-specific reference range, ideally <2.5 mIU/L 2, 1
  • Free T4 in the upper half of the normal range 2

Adjust levothyroxine by 12.5-25 mcg increments based on TSH results 2, 1. Approximately 25-50% dose increases are typically needed during pregnancy in women with pre-existing hypothyroidism, though this patient has new-onset disease 2, 1.

Special Considerations at 27 Weeks Gestation

At 27 weeks, you are in the third trimester where:

  • Levothyroxine requirements are typically at their peak during pregnancy 2
  • The fetus still depends substantially on maternal thyroid hormone for neurodevelopment 2
  • Rapid normalization of maternal thyroid function is essential to prevent ongoing fetal harm 2

Do not use a conservative "start low, go slow" approach in this clinical scenario—the standard full replacement dose of 1.6 mcg/kg/day is appropriate and necessary 1, 5.

Critical Pitfalls to Avoid

  • Never delay treatment to "confirm" the diagnosis with repeat testing—overt hypothyroidism in pregnancy requires immediate treatment 2
  • Do not start with 25-50 mcg/day as you would in elderly patients with cardiac disease; pregnancy is a unique situation requiring full replacement immediately 2, 5
  • Avoid waiting for symptoms to develop before checking TSH, as fetal harm can occur before maternal symptoms appear 2
  • Never use combination T4/T3 therapy during pregnancy—levothyroxine monotherapy is the only appropriate treatment as T3 does not adequately cross the placenta 2

Patient Education Points

Instruct the patient to:

  • Take levothyroxine on an empty stomach, 30-60 minutes before breakfast, for optimal absorption 2, 3
  • Maintain at least 4 hours separation from iron, calcium supplements, or antacids 2, 3
  • Understand that thyroid hormone is critical for fetal brain development and treatment cannot be delayed 2
  • Report any symptoms of overtreatment (palpitations, tremor, heat intolerance) or undertreatment (persistent fatigue, cold intolerance) 2

Post-Delivery Management

Reduce levothyroxine dose to pre-pregnancy levels immediately after delivery and monitor serum TSH 4-8 weeks postpartum 1. Many women with pregnancy-induced hypothyroidism may not require lifelong treatment, so reassessment postpartum is essential 2.

References

Guideline

Initial Treatment for Elevated TSH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Substitution of thyroid hormones].

Der Internist, 2008

Research

LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2016

Research

Levothyroxine therapy in patients with thyroid disease.

Annals of internal medicine, 1993

Related Questions

What is the recommended approach for converting a patient from Tirosint (levothyroxine) to Synthroid (levothyroxine)?
What are the pharmacokinetic considerations for dosing Synthroid (levothyroxine) in hypothyroidism?
How to adjust Thyronorm (levothyroxine) dose for a patient with severe hypothyroidism and elevated TSH?
What is the estimated weight-based dose for a patient taking 2 micrograms (mcg) of Levothyroxine (thyroid hormone replacement)?
What management approach is recommended for a patient on levothyroxine with a low TSH level and iron deficiency?
Is fatigue a side effect of the combined oral contraceptive Yaz (drospirenone 3 mg/ethinyl estradiol 20 µg) in healthy adult women?
What is the appropriate levothyroxine (synthetic thyroxine) starting dose and monitoring plan for a hypothyroid adult, including adjustments for elderly patients, those with coronary artery disease or heart failure, and pregnant women?
In a 52-year-old ex‑smoker whose father had an ischemic stroke at age 50, should aspirin therapy be initiated for primary prevention?
What are the cardiogenic and non‑cardiogenic causes of pulmonary edema?
Has the patient experienced an ischemic stroke before age 50, and should his/her siblings receive low‑dose aspirin for primary prevention?
I developed brown facial macules after the COVID‑19 pandemic, possibly related to mask use or COVID‑19 treatment (systemic steroids, hydroxychloroquine); could this be post‑inflammatory hyperpigmentation or melasma and how should I treat it?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.